Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, continues to be a major threat to populations worldwide. Whereas the disease is treatable, the
drug regimen is arduous at best with the use of four antimicrobials over a six-month period. There is clearly a pressing need for the development of new
therapeutics. One potential target for structure-based
drug design is the
enzyme RmlA, a
glucose-1-phosphate thymidylyltransferase. This
enzyme catalyzes the first step in the biosynthesis of l-
rhamnose, which is a deoxysugar critical for the integrity of the bacterium's cell wall. Here, we report the X-ray structures of M.
tuberculosis RmlA in complex with either
dTTP or
dTDP-glucose to 1.6 Å and 1.85 Å resolution, respectively. In the RmlA/
dTTP complex, two
magnesium ions were observed binding to the
nucleotide, both ligated in octahedral coordination spheres. In the RmlA/
dTDP-glucose complex, only a single
magnesium ion was observed. Importantly, for RmlA-type
enzymes with known three-dimensional structures, not one model shows the position of the
magnesium ion bound to the
nucleotide-linked
sugar. As such, this investigation represents the first direct observation of the manner in which a
magnesium ion is coordinated to the RmlA product and thus has important ramifications for structure-based
drug design. In the past, molecular modeling procedures have been employed to derive a three-dimensional model of the M.
tuberculosis RmlA for
drug design. The X-ray structures presented herein provide a superior molecular scaffold for such endeavors in the treatment of one of the world's deadliest diseases.